Literature DB >> 27066313

The times they are a-changin': the Cachexia Conference goes annual.

Stephan von Haehling1, Stefan D Anker1.   

Abstract

Entities:  

Year:  2016        PMID: 27066313      PMCID: PMC4771211          DOI: 10.1002/jcsm.12110

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


× No keyword cloud information.
The field of cachexia and muscle wasting research has started to move, slowly but steadily, and large and small companies alike are increasing their efforts into the development of new drug therapies for cachexia, sarcopenia and frailty. Recent research has focused on novel screening tools1 and biomarker research to enable an early diagnosis of wasting,2, 3 but also on the pathophysiological understanding of the wasting process4, 5 nutrition,6, 7 exercise, particularly in cachectic cancer patients,8, 9, 10 and novel therapeutic approaches.11, 12, 13 Even though the pathophysiological understanding is making rapid progress – if not by the minute or day, then by the week for sure – recent phase III trials have failed unfortunately to translate gain in muscle mass into gain in muscle function, i.e. more exercise capacity or strength or better stair climbing power. The Cachexia Conference, closely affiliated with this journal and the Society of Sarcopenia, Cachexia and Wasting Disorders (SCWD), until recently held ist conferences only every other year in a different location. The Cachexia Conferences closely follow the rapid progress in the field of cachexia research. Therefore, as of this coming December, the conference will be held annually. Indeed, the 9th Cachexia Conference is due to take place on December 10‐11, 2016, in Berlin, Germany. Berlin is a city that is changing as quickly as the field of cachexia research. Following the lines of Bob Dylan's song The Times They Are A‐changin’, we invite researchers to come to Berlin to share their enthusiam and insight: We would like to make the conference a very hands‐on meeting with (likely) no parallel sessions and a programme made by the audience. We hereby call for your session proposals to be send to Mrs Monika Diek at the SCWD office (conference2016@cachexia.info). Please do so by 15th April, 2016. As we start to go annual, we will still hold a big Cachexia Conference for 3 full days (as done in Paris) every 2 years, and every other 2 years the meeting is a 2‐day affair. As the field gains momentum, we may change this in the future, but fort he time being this seems tob e prudent. So please, safe the date and come to Berlin on 10/11 December, 2016. And send us your session proposals.

Conflict of interest

None declared.
  14 in total

1.  Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.

Authors:  José M Garcia; John Friend; Suzan Allen
Journal:  Support Care Cancer       Date:  2012-06-16       Impact factor: 3.603

Review 2.  The wasting continuum in heart failure: from sarcopenia to cachexia.

Authors:  Stephan von Haehling
Journal:  Proc Nutr Soc       Date:  2015-08-12       Impact factor: 6.297

3.  Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer.

Authors:  Lee W Jones; Pamela S Douglas; Neil D Eves; P Kelly Marcom; William E Kraus; James E Herndon; Brant A Inman; Jason D Allen; Jeffrey Peppercorn
Journal:  BMC Cancer       Date:  2010-10-06       Impact factor: 4.430

4.  A framework for prescription in exercise-oncology research.

Authors:  John P Sasso; Neil D Eves; Jesper F Christensen; Graeme J Koelwyn; Jessica Scott; Lee W Jones
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-05-11       Impact factor: 12.910

5.  Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma.

Authors:  Weijie Gu; Guiming Zhang; Lijiang Sun; Qi Ma; Yue Cheng; Hailiang Zhang; Guohai Shi; Yao Zhu; Dingwei Ye
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-20       Impact factor: 12.910

6.  Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients.

Authors:  David Pj van Dijk; Marcel Cg van de Poll; Alastair Gw Moses; Thomas Preston; Steven Wm Olde Damink; Sander S Rensen; Nicolaas Ep Deutz; Peter B Soeters; James A Ross; Kenneth Ch Fearon; Cornelis Hc Dejong
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-20       Impact factor: 12.910

Review 7.  Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review.

Authors:  Antonio Jose Grande; Valter Silva; Matthew Maddocks
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-07-07       Impact factor: 12.910

8.  Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.

Authors:  Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-11       Impact factor: 12.910

9.  An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin.

Authors:  Philip T Leese; John M Trang; Robert A Blum; Eleanor de Groot
Journal:  Clin Pharmacol Drug Dev       Date:  2015-02-09

10.  Request for regulatory guidance for cancer cachexia intervention trials.

Authors:  Kch Fearon; J M Argiles; V E Baracos; R Bernabei; Ajs Coats; J Crawford; N E Deutz; W Doehner; W J Evans; L Ferrucci; J M Garcia; R J Gralla; A Jatoi; K Kalantar-Zadeh; M Lainscak; J E Morley; M Muscaritoli; M I Polkey; G Rosano; F Rossi-Fanelli; A M Schols; F Strasser; B Vellas; S von Haehling; S D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-11       Impact factor: 12.910

View more
  2 in total

Review 1.  Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.

Authors:  Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-12       Impact factor: 12.910

Review 2.  Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure.

Authors:  Helena Krysztofiak; Marta Wleklik; Jacek Migaj; Magdalena Dudek; Izabella Uchmanowicz; Magdalena Lisiak; Grzegorz Kubielas; Ewa Straburzyńska-Migaj; Maciej Lesiak; Marta Kałużna-Oleksy
Journal:  Clin Interv Aging       Date:  2020-11-02       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.